Customize your experience
You decide what information you want to see on your Sanofi Campus
More about Science
Choose a therapeutic area to find related scientific content
Tubercolosis
Diabetes
Anxiety
Oncology
Dermatology
Insomia
Antimicrobials
Thrombosis
Vaccines
Latest Articles
Explore the latest scientific articles and videos
Our Products
Praluent ®
Alirocumab is a fully human IgG1 monoclonal antibody. It’s a PCSK9 inhibitor that is administered subcutaneously.
.png/jcr:content/4%20(1).png)
PRIFTIN®
contains rifapentine which belongs to the rifamycin class of antibiotics. It is used with other anti-tuberculosis (TB) medicines to treat inactive (latent) tuberculosis infection and to prevent it’s progression to active tuberculosis disease in people aged 2 years and older who are at risk.
RIFAFOUR e-275
a combination of four first line agents used in the treatment of tuberculosis. It contains: Rifampicin, Isoniazid, Pyrazinamide and Ethambutol.
Sintrine®
Sintrine Oral Granules is indicated in paediatric patients 2 to 5 years of age for the prophylaxis and treatment of atopic asthma
Sintrine 4 chewable tablets are indicated in paediatric patients 2 to 5 years of age for the prophylaxis and chronic treatment of atopic asthma
Sintrine 5 chewable tablets are indicated in paediatric patients from 6 years of age for the prophylaxis and chronic treatment of atopic asthma
Sintrine 10 film-coated tablets are indicated in adults and children 15 years of age and older for the prophylaxis and chronic treatment of atopic asthma
Soliqua®
Soliqua® combines lixisenatide, a GLP-1 receptor agonist, and insulin glargine 100U/ml to help adult patients with Type 2 diabetes manage fasting and postprandial glycaemia in a single once-daily injection.
Stilnox MR®
STILNOX MR 12,5 is indicated in adults below the age of 65 years, and only when the disorder is severe, disabling or subjecting the individual to extreme distress.
Treatment should be as short as possible. Generally, the duration of treatment varies from four days to two weeks with a maximum, including the tapering off process, of four weeks. In certain cases extension beyond the maximum treatment period may be necessary; if so, it should not take place without re-evaluation of the patient’s status.
Treatment should be started with the lowest recommended dose. The maximum dose should not be exceeded
Storwin®
Rosuvastatin exerts its effect through a mevalonic acid-like moiety that competitively inhibits HMG-CoA reductase. By reducing the conversion of HMG-CoA to mevalonate, rosuvastatin inhibits the early and rate-limiting step in cholesterol biosynthesis. The primary site of action is the liver, the target organ for cholesterol-lowering effects. Rosuvastatin increases the number of hepatic low density lipoprotein (LDL) receptors on the cell-surface, enhancing uptake and catabolism of LDL and inhibits the hepatic synthesis of very low density lipoprotein (VLDL), thereby reducing the total number of VLDL and LDL particles.
Toujeo®
Toujeo® is a long-acting recombinant human insulin analogue indicated for the treatment of diabetes mellitus in adults, adolescents and children from the age of 6 years.
Urbanol
Urbanol belongs to the class of Tranquillisers
Chemically Urbanol is a 1,5-benzodiazepine.
Urbanol is used in the treatment of anxiety in neurotic patients and for pre-operative medication. It may be effective in relieving the acute symptoms of the alcohol withdrawal syndrome, but has no specific usefulness in the treatment of psychotic patients.
Urbanol is only indicated when the disorder is severe, disabling or subjecting the individual to extreme stress.
.png/jcr:content/1%20(2).png)
WINTHROP ISONIAZID
contains Isoniazid. Isoniazid is indicated alone for the prophylaxis of tuberculosis and in conjunction with other antituberculosis medicine for the treatment of tuberculosis.
▼This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.